Tel:
Fax:
Email:
Creative Biolabs

Aggregation Kits

Protein aggregation is a biological phenomenon in which proteins misfold and change their conformation to form aggresome. Aggresomes are inclusion bodies formed by a group of abnormally stacked proteins. Aggregates often form in response to cellular stress and provide a cellular defense mechanism by detaching misfolded proteins, ultimately leading to their clearance by autophagy. In addition, the formation of protein aggregates is a hallmark of several human diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS).

Types of Protein Aggregation in Neurodegeneration

Disease Aggregating Protein/Peptide
Alzheimer's Disease (AD) Amyloid β-peptide 1-40/1-42, Tau protein
Parkinson's Disease (PD) α-synuclein (α-syn)
Frontotemporal Dementia (FTLD) Tau protein
Amyotrophic Lateral Sclerosis (ALS) Neurofilament protein, SOD1, DNA/RNA binding proteins (FUS)
Huntington's Disease (HD) Huntingtin
Prion Diseases Prion protein

Case Study

Originally designed to identify the infectious form of prion protein in Creutzfeldt-Jakob disease, the Seed Amplification Assay (SAA), also referred to as Real-Time Quaking-Induced Conversion (RT-QuIC) or Protein Misfolding Cyclic Amplification (PMCA), was created. After being developed successfully to diagnose Creutzfeldt-Jakob disease, SAAs were modified to identify the α-syn associated with the disorder. While measuring α-syn directly in monomeric or oligomeric forms as a biomarker has been difficult and has not shown reliable findings, α-syn SAA enables precise and sensitive quantification of α-syn seeds in cerebrospinal fluid (CSF).

Fig 1 Workflow of the SAA assay for alpha-synuclein. (Creative Biolabs Original)

Features of Our Aggregation Kits

  • A reliable and uncomplicated test that eliminates the need for genetically modified cell lines or non-physiological protein alterations.
  • Suitable for screening small-molecule compounds with potential therapeutic value over a wide range of operating conditions.
  • Provide sensitive cell-based drug response assays to identify inhibitors relevant to neurodegenerative diseases in a real cellular context.

Pathological amyloid aggregation of proteins plays an important role in the typing, diagnosis, and drug development of neurodegenerative diseases. We can customize your protein aggregation assay to specify the most appropriate plan for your project.

If the product you are looking for is not listed, or if you are interested in one of our custom protein aggregation assays, please contact us. Our experts will assist you in selecting the right product for your specific application and help you find the ideal product for the task.

For Research Use Only. Not For Clinical Use.

Target

Related Products
Loading...
HOT Alpha Synuclein Aggregation Kit [CAT#: NRZP-1122-ZP15]

This kit is designed for an accurate quantitative measurement of alpha synuclein aggregation in brain extracts.

HOT Human Tau Aggregation Kit [CAT#: NRP-0322-P2173]

Alzheimer's disease

The Tau Aggregation kit is designed for the fast detection of human Tau aggregates in brain tissues and cell cultures.

Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
Inquiry Basket
compare

Send inquiry